Conference Coverage

Coming soon!

Publish date: October 4, 2019

 

Check back later this month for top news from the 2019 AANEM Annual Meeting in Austin.

Recommended Reading

Is pro soccer a risk factor for ALS?
MDedge Neurology
Physical activity slows cognitive decline in patients with Parkinson’s disease
MDedge Neurology
Ruzurgi approved for Lambert-Eaton myasthenic syndrome in patients under age 17
MDedge Neurology
Can an antisense oligonucleotide benefit patients with SOD1-ALS?
MDedge Neurology
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease
MDedge Neurology
Novel genetic therapy reduces key protein in Huntington’s disease
MDedge Neurology
Study refines ALS risk among first-degree relatives of patients with disease
MDedge Neurology
NIH launches 5-year, $10 million study on acute flaccid myelitis
MDedge Neurology
Peripheral nervous system events have lasting impact on SLE patients
MDedge Neurology
Can a novel steroidal anti-inflammatory drug benefit patients with Duchenne muscular dystrophy?
MDedge Neurology